FDA declines to approve Nabriva's antibiotic for urinary tract infections

The U.S. Food and Drug Administration on Tuesday declined to approve Nabriva Therapeutics Plc's antibiotic for complicated urinary tract infections (cUTI), even as the nation grapples with the growing problem of antibiotic resistance.


from Reuters: Health News https://reut.rs/2GMpDjh

Comentarii

Postări populare de pe acest blog

Telehealth hubs offer care options for people living on the edge the virtual world

Overuse on cattle feedlots is a key factor in antibiotic resistance, report says

Bringing Your Ballpark Food Favorites Home